Lifecore Biomedical, Inc. LFCR Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s finance lease liabilities?
- Lifecore Biomedical, Inc. (LFCR) reported finance lease liabilities of $5.64M in Q1 2026.
- How has Lifecore Biomedical, Inc.'s finance lease liabilities changed year-over-year?
- Lifecore Biomedical, Inc.'s finance lease liabilities decreased by 2.7% year-over-year, from $5.8M to $5.64M.
- What is the long-term trend for Lifecore Biomedical, Inc.'s finance lease liabilities?
- Over 5 years (2021 to 2026), Lifecore Biomedical, Inc.'s finance lease liabilities has grown at a 11.3% compound annual growth rate (CAGR), from $3.31M to $5.64M.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.